Month: May 2024

Luxembourg – 25 May 2024 – Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Serica Energy, for the Belinda field development south-east of the Triton FPSO. The Belinda field is operated by Serica Energy and located approximately 190 kilometres east of Aberdeen in the UK Central North Sea, with a water depth of 95 metres. The contract scope includes project management, engineering, procurement, construction and installation (EPCI) of a 5-kilometre 8” production pipeline with a 3” piggy-backed gas lift line and an electro-hydraulic controls (EHC) umbilical. Subsea7’s scope also includes associated subsea structures and tie-ins to the Triton Floating Production Storage & Offloading (FPSO) vessel operated by Dana Petroleum, via an existing production manifold near the Triton riser base...

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2,3 Fabhalta showed a favorable safety profile with no new safety signals1 C3G, an ultra-rare kidney disease caused by alternative complement pathway overactivation, progresses to kidney failure in ∼50% of patients within 10 years4-7; currently there are no treatments approved for C3G7-9  Fabhalta, an oral Factor B inhibitor of the alternative complement pathway, selectively targets the underlying cause of C3G1; late-stage development program ongoing across several other rare diseases10-13Basel, May 25, 2024 – Novartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan)...

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 weeks1Endothelin A (ETA) receptor activation contributes to elevated proteinuria in IgAN2-5; atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent proteinuria and preserve kidney function for a broad patient population1 IgAN is a heterogeneous, progressive, rare kidney disease with a need for effective, targeted therapies6,7; up to 30% of patients with persistent proteinuria (≥1 g/day) progress to kidney failure within 10 years8Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action...

TORONTO, May 24, 2024 (GLOBE NEWSWIRE) — MacDonald Mines Exploration Ltd. (TSX-V: BMK, OTC: MCDMF) (“MacDonald Mines” or the “Company”) has discovered inconsistencies in certain assay results from the Scadding gold prospect that were previously publicly announced by way of press releases and which may also have been disclosed or used in certain other disclosure documents, such as the National Instrument 43-101 technical report on the Scadding gold project dated October 18, 2019. Accordingly, the company hereby withdraws all its previously announced assay results for the Scadding gold project and advises that such results and the disclosure that such results are based on should not be relied upon. The company is conducting a detailed review and comparison of the assay results from the Scadding gold project with the company’s...

Toronto, May 24, 2024 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Fund (NEO:FGX), is pleased to announce the monthly distribution payable on the Shares of the below listed Fund.Faircourt Funds Trading Symbol Distribution Amount (per share/unit) Ex-Dividend Date Record Date Payable DateFaircourt Gold Income Corp. FGX $0.024 May 31, 2024 May 31, 2024 June 14, 2024Faircourt Asset Management Inc. is the Investment Advisor for Faircourt Gold Income Corp. This press release is not for distribution in the United States or over United States wire services. For further information on the Faircourt Funds, please visit www.faircourtassetmgt.com or please contact 1-800-831-0304. You will usually pay brokerage fees to your dealer if you purchase or sell Shares of the Fund on the NEO Exchange or...

MELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires the timely filing of all required periodic reports...

CALGARY, Alberta, May 24, 2024 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) announces the departure of Vice President Operations and Customer Experience, Ryan Pilsner, effective today. On behalf of the employees and Board of Directors, the Company thanks Ryan for his contribution to Questor and wishes him all the best in his future endeavours. ABOUT QUESTOR TECHNOLOGY INC. Questor Technology Inc., incorporated in Canada under the Business Companies Act (Alberta) is an environmental emissions reduction technology company founded in 1994, with global operations. The Company is focused on clean air technologies that safely and cost effectively improve air quality, support energy efficiency and greenhouse gas emission reductions. The Company designs, manufactures and services high efficiency...

MINNETONKA, Minn., May 24, 2024 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (“Pineapple”), a leading provider of sustainable solar energy and backup power to households and small business, announced today that its New York-based subsidiary SUNation signed a 1.95-megawatt project. SUNation will begin work on this large-scale commercial installation in early July. The project, to be installed on a large industrial building in New York, will feature an expedited installation. The developer has more than 200 MW of energy in their projected renewables pipeline nationally. They chose SUNation due to their extensive interconnection knowledge in the State of New York as well as their successful track record of delivering projects on time and on budget. “Projects of this size and complexity can take years to develop. This project went from...

SÃO PAULO, Brazil, May 24, 2024 (GLOBE NEWSWIRE) — Lavoro Limited (Nasdaq: LVRO; LVROW), the first U.S.-listed agricultural inputs retailer in Latin America, will issue its financial results for the fiscal third quarter 2024 after market close on Monday, June 3, 2024. Lavoro management will host a conference call and audio webcast that afternoon at 6:00 p.m. ET (7:00 p.m. BRT) to discuss the results. Conference Call Details Title: Lavoro Fiscal Third Quarter 2024 Earnings Conference Call Event Date: Monday, June 3, 2024 Time: 6:00 p.m. ET (7:00 p.m. BRT) Participant Numbers: 1-877-407-9716 (U.S.), 1-201-493-6779 (International) Event Link: https://ir.lavoroagro.com/disclosure-and-documents/events/ For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Monday, June 17,...